Estimate the anticipated benefit from Lutetium-177-DOTATATE
External Validation of a Clinical Score for Patients With Neuroendocrine [...]
Theranostics: A Smart Bomb for Cancer
MSK News/MSK News Winter 2021/2022 In the basement of the [...]
Encouraging Early Results for Prostate Cancer Screening
Dosing of First Patients Shows Encouraging Early Results in the [...]
Warm and Hopeful Wishes 2022
Getting into 2022 with a lot of things to do! [...]
Radiotheranostics Today by the Oncidium foundation
Voicing the Challenges and Opportunities of Radiotheranostics for Cancer Care [...]
Get more insight from the NOBLE Registry Website
Revealing the website of the NOBLE Registry : get more [...]
Q&A: How a new imaging tool helps to better stage prostate cancer
Q&A by Doctor Jeremie Calais on how PSMA PET imaging [...]
Scandium radionuclides for theranostic applications
Learn more about the upcoming new radionuclide family of Scandium: [...]
Patient Management with Lu-177–PSMA-617 in the Clinic
Patient Management and Operationalizing Lutetium-177–PSMA-617 for Metastatic Castration Resistant Prostate [...]
Health Policy Partnership Framework
The Oncidium foundation is endorsing the Health Policy Partnership Framework, [...]